Menstrual Pain Relief Complete Tablet, Film Coated
NDC Package 83059-0119-8
Package Information
Menstrual Pain Relief Complete (acetaminophen, pyrilamine maleate, caffeine) tablets is adults and children 12 years and over:do not take more than the recommended doseadults and children 12 years and over: take 2 caplets with waterrepeat every 6 hours, as neededdo not exceed 6 caplets per daychildren under 12 years: ask a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Shield Pharmaceuticals Corp, this product is identified by NDC 83059-0119 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 1597298 - acetaminophen 500 MG / caffeine 60 MG / pyrilamine maleate 15 MG Oral Tablet
- RxCUI: 1597298 - APAP 500 MG / Caffeine 60 MG / Pyrilamine Maleate 15 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83059 - Shield Pharmaceuticals Corp
- 83059-0119 - Menstrual Pain Relief Complete
- 83059-0119-8 - 80 TABLET, FILM COATED in 1 BOTTLE
- 83059-0119 - Menstrual Pain Relief Complete
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83059-0119-8 identifies a specific commercial package of 80 tablet, film coated in 1 bottle of Menstrual Pain Relief Complete, a human over the counter drug labeled by Shield Pharmaceuticals Corp. This tablet, film coated is formulated for oral use and contains acetaminophen; caffeine; pyrilamine maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shield Pharmaceuticals Corp on December 05, 2025. The current certification is valid through December 31, 2026.
How is this Shield Pharmaceuticals Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83059011908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.